{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT02474342",
      "OrgStudyIdInfo": {
        "OrgStudyId": "BRM-15-01"
      },
      "Organization": {
        "OrgFullName": "Seoul National University Hospital",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Autologous Adipose Tissue Derived Mesenchymal Stem Cells for Rotator Cuff Disease",
      "OfficialTitle": "Safety and Efficacy of Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Rotator Cuff Disease"
    },
    "StatusModule": {
      "StatusVerifiedDate": "May 2016",
      "OverallStatus": "Completed",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "July 7, 2015"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "November 2016",
        "PrimaryCompletionDateType": "Actual"
      },
      "CompletionDateStruct": {
        "CompletionDate": "November 7, 2016",
        "CompletionDateType": "Actual"
      },
      "StudyFirstSubmitDate": "June 2, 2015",
      "StudyFirstSubmitQCDate": "June 16, 2015",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "June 17, 2015",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "March 6, 2017",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "March 7, 2017",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Principal Investigator",
        "ResponsiblePartyInvestigatorFullName": "Hyunchul Jo",
        "ResponsiblePartyInvestigatorTitle": "Associate Professor, SMG-SNU Boramae Medical Center",
        "ResponsiblePartyInvestigatorAffiliation": "Seoul National University Hospital"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Seoul National University Hospital",
        "LeadSponsorClass": "OTHER"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "The purpose of this study is to evaluate safety and efficacy of Autologous Adipose Tissue Derived Mesenchymal Stem Cells injection in patient with Rotator Cuff disease."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Rotator Cuff Disease"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Not Applicable"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "N/A",
        "DesignInterventionModel": "Single Group Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "18",
        "EnrollmentType": "Actual"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Autologous Adipose Tissue derived MSCs",
            "ArmGroupType": "Experimental",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Autologous Adipose Tissue Derived MSCs Transplantation"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "Autologous Adipose Tissue Derived MSCs Transplantation",
            "InterventionDescription": "Study drugs: Autologous adipose tissue derived MSCs\n\nInjection dosage and volume of the study drugs:\n\nLow dose: 1x10e7 cells/3mL\nNumber of injections : only once during the study period\nDevice: Ultrasound\nInjection technique: Injection into the lesion by investigator",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Autologous Adipose Tissue derived MSCs"
              ]
            }
          },
          {
            "InterventionType": "Biological",
            "InterventionName": "Autologous Adipose Tissue Derived MSCs Transplantation",
            "InterventionDescription": "Study drugs: Autologous adipose tissue derived MSCs\n\nInjection dosage and volume of the study drugs:\n\nMid dose: 5x10e7 cells/3mL\nNumber of injections : only once during the study period\nDevice: Ultrasound\nInjection technique: Injection into the lesion by investigator",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Autologous Adipose Tissue derived MSCs"
              ]
            }
          },
          {
            "InterventionType": "Biological",
            "InterventionName": "Autologous Adipose Tissue Derived MSCs Transplantation",
            "InterventionDescription": "Study drugs: Autologous adipose tissue derived MSCs\n\nInjection dosage and volume of the study drugs:\n\nHigh dose: 1x10e8 cells/3mL\nNumber of injections : only once during the study period\nDevice: Ultrasound\nInjection technique: Injection into the lesion by investigator",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Autologous Adipose Tissue derived MSCs"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "SPADI(Shoulder pain and disability index)Score",
            "PrimaryOutcomeDescription": "The Shoulder Pain and Disability Index (SPADI) is a self-administered questionnaire that consists of two dimensions, one for pain and the other for functional activities. The pain dimension consists of five questions regarding the severity of an individual's pain. Functional activities are assessed with eight questions designed to measure the degree of difficulty an individual has with various activities of daily living that require upper-extremity use.",
            "PrimaryOutcomeTimeFrame": "24 weeks"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Constant-Murley score",
            "SecondaryOutcomeDescription": "The Constant score assesses pain, function, ROM, and strength. Pain is allotted a maximum of 15 points, activities of daily living (function)20 points, ROM 40 points, and strength 25 points. The component scores are summated to achieve a maximum possible total score of 100.",
            "SecondaryOutcomeTimeFrame": "24 weeks"
          },
          {
            "SecondaryOutcomeMeasure": "Visual Analog Scale_pain in motion",
            "SecondaryOutcomeTimeFrame": "24 weeks"
          },
          {
            "SecondaryOutcomeMeasure": "Changes in the size of rotator cuff tears determined by MRI",
            "SecondaryOutcomeTimeFrame": "24 weeks"
          },
          {
            "SecondaryOutcomeMeasure": "Changes in the size of rotator cuff tears determined by arthroscopy",
            "SecondaryOutcomeTimeFrame": "24 weeks"
          },
          {
            "SecondaryOutcomeMeasure": "Adverse event",
            "SecondaryOutcomeTimeFrame": "24weeks"
          }
        ]
      },
      "OtherOutcomeList": {
        "OtherOutcome": [
          {
            "OtherOutcomeMeasure": "ASES (American Shoulder and Elbow Surgeons Evaluation form)",
            "OtherOutcomeTimeFrame": "24 weeks"
          },
          {
            "OtherOutcomeMeasure": "UCLA (University of California, Los Angeles) score",
            "OtherOutcomeTimeFrame": "24 weeks"
          },
          {
            "OtherOutcomeMeasure": "DASH (Disabilities of the Arm, Shoulder and Hand )",
            "OtherOutcomeTimeFrame": "24 weeks"
          },
          {
            "OtherOutcomeMeasure": "WORC (Western Ontario Rotator Cuff Index)",
            "OtherOutcomeTimeFrame": "24 weeks"
          },
          {
            "OtherOutcomeMeasure": "OSS (Oxford Shoulder Scores)",
            "OtherOutcomeTimeFrame": "24 weeks"
          },
          {
            "OtherOutcomeMeasure": "SANE (Single Assessment Numeric Evaluation)",
            "OtherOutcomeTimeFrame": "24 weeks"
          },
          {
            "OtherOutcomeMeasure": "SST (Simple Shoulder Test)",
            "OtherOutcomeTimeFrame": "24 weeks"
          },
          {
            "OtherOutcomeMeasure": "Visual Analog Scale_pain at rest",
            "OtherOutcomeTimeFrame": "24 weeks"
          },
          {
            "OtherOutcomeMeasure": "Visual Analog Scale_pain at night",
            "OtherOutcomeTimeFrame": "24 weeks"
          },
          {
            "OtherOutcomeMeasure": "Visual Analog Scale_worst pain",
            "OtherOutcomeTimeFrame": "24 weeks"
          },
          {
            "OtherOutcomeMeasure": "Visual Analog Scale_satisfaction",
            "OtherOutcomeTimeFrame": "24 weeks"
          },
          {
            "OtherOutcomeMeasure": "Shoulder ROM (Forward flexion, Abduction, External rotation & Internal rotation at 0 degree)",
            "OtherOutcomeTimeFrame": "24 weeks"
          },
          {
            "OtherOutcomeMeasure": "Muscle strength (lb)",
            "OtherOutcomeDescription": "The strength the supraspinatus, infraspinatus,and subscapularis was measured using a handheld electronic scale",
            "OtherOutcomeTimeFrame": "24 weeks"
          },
          {
            "OtherOutcomeMeasure": "Body weight (Kg)",
            "OtherOutcomeDescription": "To determine the overall safety of Autologous Adipose Tissue Derived Mesenchymal Stem Cells carrier using body weight",
            "OtherOutcomeTimeFrame": "24 weeks"
          },
          {
            "OtherOutcomeMeasure": "Body temperature (â„ƒ)",
            "OtherOutcomeDescription": "To determine the overall safety of Autologous Adipose Tissue Derived Mesenchymal Stem Cells carrier using body temperature",
            "OtherOutcomeTimeFrame": "24 weeks"
          },
          {
            "OtherOutcomeMeasure": "Pulse rate (beats per minute)",
            "OtherOutcomeDescription": "To determine the overall safety of Autologous Adipose Tissue Derived Mesenchymal Stem Cells carrier using pulse rate",
            "OtherOutcomeTimeFrame": "24 weeks"
          },
          {
            "OtherOutcomeMeasure": "Blood Pressure (mmHg)",
            "OtherOutcomeDescription": "To determine the overall safety of Autologous Adipose Tissue Derived Mesenchymal Stem Cells carrier using blood pressure",
            "OtherOutcomeTimeFrame": "24 weeks"
          },
          {
            "OtherOutcomeMeasure": "CBC(complete blood count)",
            "OtherOutcomeDescription": "The measures are composite.",
            "OtherOutcomeTimeFrame": "24 weeks"
          },
          {
            "OtherOutcomeMeasure": "Blood chemistry",
            "OtherOutcomeDescription": "The measures are composite.",
            "OtherOutcomeTimeFrame": "24 weeks"
          },
          {
            "OtherOutcomeMeasure": "Urinalysis",
            "OtherOutcomeDescription": "The measures are composite.",
            "OtherOutcomeTimeFrame": "24weeks"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Participants should meet all the inclusion criteria. Patients must consent in writing to participate in the study by signing and dating an informed consent document approved by IRB indicating that the patient has been informed of all pertinent aspects of the study prior to completing any of the screening procedures\n\nInclusion Criteria:\n\nMale or female 19 years of age and older.\nPatients who have unilateral shoulder pain.\nPatients who have had pain at least for 3 months and do not respond to conservative treatment.\nPatients who have a partial-thickness rotator cuff tear confirmed with magnetic resonance imaging (MRI) or ultrasonography (US).\n\nExclusion Criteria:\n\nParticipants who met a single condition were excluded from the study\n\nPatients who received any drug by subacromial injection for treatment within 3 months prior to this enrollment.\nPatients who have a history of shoulder trauma including dislocation, subluxation, and fracture, breast cancer, or surgery around shoulder, neck and upper back within 6 months prior to this enrollment.\nPatients who have a full-thickness rotator cuff tear\nPatients who have radiological findings of malignancy, osteoarthritis of the glenohumeral joint, and skeletal abnormalities decreasing the subacromial space\nPatients with symptomatic cervical spine disorders\nPatients with concurrent bilateral shoulder pain\nPatients with adhesive capsulitis, acromioclavicular arthropathy, polyarthritis, infectious arthritis, rheumatoid arthritis or diagnosed fibromyalgia\nPatients with neurological deficit\nPregnant women or lactating mothers\nFertile woman of childbearing potential not willing to use adequate contraception for the study duration\nPatients taking anticoagulants\nPatients who are positive serology for human immunodeficiency (HIV), hepatitis B (HBV) or hepatitis C (HCV) and syphilis\nPatients with serious condition which can affect this study such as severe cardiovascular diseases, renal diseases, liver diseases, endocrine diseases, and cancers\nPatients who are difficulty participating in data collection due to communication problem and serious mental illness\nPatients are unable to come into the clinic for regular follow-up\nPatients who had participated in other clinical trials within 3 months prior to this study.\nPatients who the principal investigator considered inappropriate for the clinical trial due to any other reasons than those listed above.",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "19 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Chris H. Jo, M.D., Ph.D",
            "OverallOfficialAffiliation": "Joint & Spine Center, SMG-SNU Boramae Medical Center, Department of Orthopedic Surgery, Seoul National University College of Medicine",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Joint & Spine Center, SMG-SNU Boramae Medical Center, Department of Orthopedic Surgery, Seoul National University College of Medicine",
            "LocationCity": "Seoul",
            "LocationCountry": "Korea, Republic of"
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    }
  }
}